Company news
Orthocell Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
1st Patient Recruited in Ortho-ATI Shoulder Tendon Study
September 4, 2017
Preliminary Final Report
August 31, 2017
Ortho-ACI on Australian Register of Therapeutic Goods
May 29, 2017
Ethics Approval Received for Pilot Ortho-ATI Tendon Study
April 30, 2017
Response to ASX Query
April 10, 2017
Singapore Patent for CelGro SMART Graft Received
March 27, 2017
Orthocell Announces Gluteal Tendon Publication
February 26, 2017
Initial Results Positive for CelGro Human Nerve Regeneration
February 21, 2017
Orthocell Submits US Regulatory Application for CelGro
February 7, 2017
Orthocell Cell Factory Patent Granted in Europe
January 30, 2017
Orthocell Announces Collaboration with Johnson & Johnson
January 11, 2017
Orthocell Announces $4 million Capital Raising
December 6, 2016
Orthocell Announces Growth Factor - Cell factory Publication
October 30, 2016
Approval for CelGro Human Nerve Regeneration Study Received
October 17, 2016
Ethics Approval for Pivotal Ortho ATI Tendon Study Received
July 11, 2016
United States Tendon Stem Cell and Scaffold Patent Obtained
June 20, 2016
Chinese Patent Received Covering Celgro SMART Graft
June 17, 2016
Early Positive Results for CelGro in Human Tendon Study
June 15, 2016
Orthocell Receives Approval for Human Hip Study Using Celgro
May 3, 2016
Cell Factory Concept Further Validated in Leading Journal
April 20, 2016
Tendon Data Presented at International Hip Conference
March 30, 2016
Admission to Official List
March 30, 2016
Patent Received Use of Ortho-ATI for Rotator Cuff Injuries
March 30, 2016
Orthocell generates first royalties from China
March 30, 2016
Ortho-ATI Study Proves Long Term Effectiveness
March 30, 2016
First Human Tendons Grown in Laboratory
March 30, 2016
Appendix 4C - quarterly cashflow report
March 30, 2016
US Patent Received for CELGRO
March 30, 2016
Tendon Regeneration Data Presented at South Africa Meeting
March 30, 2016
Technology and Data Presentations at key Ortho Conferences
March 30, 2016
Response to ASX Price Query
March 30, 2016
Response to ASX Aware Query
March 30, 2016
Positive Initial Results Using Celgro in Dental Study
March 30, 2016
Pipeline Cartilage Product Validated in Leading Publication
March 30, 2016
Orthocell Signs Agreement with BONESUPPORT
March 30, 2016
Orthocells Cell Factory validated for bone regeneration
March 30, 2016
Orthocell Receives R&D Tax Incentive Cash Refund
March 30, 2016
Orthocell Receives Approval for Celgro Dental Study
March 30, 2016
Ortho-ATI Tendon Treatment Positive in Workers Comp Study
March 30, 2016
Ortho-ATI Data Presented at Key International Conference
March 30, 2016
Grant for World First Laboratory Grown Tendon Received
March 30, 2016
Further Details to Cell Factory Announcement and Update
March 30, 2016
First Patients in Hong Kong Treated With Ortho-ATI Therapy
March 30, 2016
Chinese Patent for Celgro Technology Granted
March 30, 2016
Orthocell to raise up to $4.4 million in US Led Placement
March 30, 2016
Orthocells Cell Factory Granted Patent in US
March 30, 2016
Orthocell Key Scaffold Patent Granted in Canada
March 30, 2016
Orthocell Key Patents Granted for Celgro and Ortho-ATI
March 30, 2016
First Singapore Patient Receives Cartilage Therapy Ortho-ACI
March 30, 2016
Approval for Human Tendon Study Using Celgro Received
March 30, 2016
Decks
The 5 newest of 35 decks. Every deck is listed under its year.
- Q1 FY27 Earnings Presentation
Earnings · 23 slides · Oct 22, 2026
- Investor Presentation (July 2026)
Investor deck · 17 slides · Jul 14, 2026
- Investor Presentation (April 2026)
Investor deck · 20 slides · Apr 20, 2026
- WA Life Sciences Broker Meets Biotech 2026
Conference · 26 slides · Mar 31, 2026
- Investor Presentation (March 2026)
Investor deck · 24 slides · Mar 31, 2026